PCRS welcome this further update of the long established, comprehensive and highly respected BTS/SIGN guideline for asthma. We are pleased that today BTS/SIGN have announced that future UK-wide guidance for the diagnosis and management of chronic asthma will be jointly produced by BTS, SIGN and NICE, something PCRS has campaigned for (Keeley & Baxter 2018).
The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.
We have guidelines on asthma from two different sources in the UK – BTS/SIGN and NICE. The British Asthma guideline from BTS/SIGN was first published in 2003 and is well established, respected and comprehensive. NICE decided to develop first a guideline on diagnosis and monitoring in asthma, and then a guideline on asthma management, and they finally came together in a single published guideline in November 2017.
Briefing document for National Respiratory Strategies – the NHS Long term plan and Lung Health Taskforce 5 year plan.
This is the most recent briefing paper on the latest update to the BTS/SIGN British Asthma Guideline.
In this regular PCRU feature we explore cases of rarer lung conditions and their presentation. In this short case discussion Fran Robinson interviews Dr Stephen Gaduzo as they discuss John, an amateur footballer who has recently been diagnosed with asthma. Originally published in the Winter 2018 edition of the Primary Care Respiratory Update.
You may also be interested in...
Asthma Right Care (ARC) is a global social movement created by the International Primary Care Respiratory Group (IPCRG) to drive change and disrupt the status quo in asthma management. Here you'll find podcasts, webinars, practical guidance and patient tools to help improve asthma outcomes.
The mMRC (Modified Medical Research Council) Dyspnoea Scale is used to assess the degree of baseline functional disability due to dyspnoea.
The PCRS Greener Respiratory Healthcare Quality Improvement (QI) toolkit has been developed to support HCPs working in the primary care setting to understand and evaluate the environmental impact of their clinical practice, identify ways to reduce this impact, set goals and priorities and evaluat
Self-reported during community pharmacy consultations in London